JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB13808

Anti-Bacillus anthracis protective antigen antibody

Anti-Bacillus anthracis protective antigen 항체

Be the first to review this product! 리뷰 제출

|

(8 제품이 사용된 논문 )

Rabbit Polyclonal Bacillus anthracis protective antigen antibody. Suitable for WB and reacts with Recombinant fragment - Bacillus anthracis samples. Cited in 8 publications.

대체 명칭 보기

pag, pXO1-110, BXA0164, GBAA_pXO1_0164, pagA, Protective antigen, PA, Anthrax toxins translocating protein, PA-83, PA83

1 이미지
Western blot - Anti-Bacillus anthracis protective antigen antibody (AB13808)
  • WB

Unknown

Western blot - Anti-Bacillus anthracis protective antigen antibody (AB13808)

Western blot analysis of Anthrax PA in recombinant protein using ab13808 (lane B) at 1 : 1000 dilution. Lane A shows the pre-bleed.

All lanes:

Western blot - Anti-Bacillus anthracis protective antigen antibody (ab13808)

false

주요 정보

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Bacillus anthracis

Applications

WB

applications

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Bacillus anthracis": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant fragment - Bacillus anthracis": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purity
Whole antiserum
보관 버퍼
Preservative: 0.05% Sodium azide Constituents: PBS, 0.05% BSA
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Bacillus anthracis protective antigen often referred to as PA plays an important role in the mechanism of anthrax toxin's entry into host cells. PA weighs approximately 83 kDa and is an essential component of B. anthracis the bacterium causing anthrax. It expresses on the surface of the bacteria and exists in the extracellular environment. Within the anthrax toxin complex PA functions mechanically by binding to host cell receptors and facilitating the entry of other anthrax toxin components lethal factor (LF) and edema factor (EF) into the host cells.
Biological function summary

Bacillus anthracis protective antigen behaves as a part of a complex specifically the anthrax toxin composed of LF EF and PA itself. PA binds to host cell’s receptors such as ANTXR1 and ANTXR2. Once PA attaches to these receptors it undergoes proteolytic cleavage to heptamer formation allowing the assembly of the toxin complex. This heptamer serves as a platform for LF and EF which subsequently translocate into the host cell's cytosol disrupting cellular processes and immune responses.

Pathways

Bacillus anthracis protective antigen operates primarily in endocytic and intracellular trafficking pathways. The binding and cleavage of PA on the host cell surface enable endocytosis of the toxin complex through clathrin-mediated pathways. This interaction with cellular components is critical for facilitating the entry of LF and EF which relate to pathways involving cellular signaling and immune response suppression. These processes highlight PA’s role in efficiently hijacking host cellular machinery for pathogenic activity.

Bacillus anthracis protective antigen is chiefly associated with anthrax a severe and sometimes lethal disease. The action of PA in the anthrax toxin contributes to systemic issues such as shock and multi-organ dysfunction. Within this context PA’s interaction with LF and EF directly correlates with the virulence and lethality of the anthrax pathogen. Understanding PA and its interactions provides invaluable insight for developing therapeutic interventions and effective anthrax antibodies aimed at neutralizing the effects of the toxin.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Protective antigen constitutes one of the three proteins composing the anthrax toxin; it mediates attachment to host cells and translocation of edema factor (EF) and lethal factor (LF) into the host cytoplasm (PubMed : 11700562, PubMed : 14507921, PubMed : 15243628, PubMed : 15326297). PA associated with LF forms the lethal toxin (LeTx) and causes death when injected; PA associated with EF forms the edema toxin (EdTx) and produces edema (PubMed : 1651334). PA induces immunity to infection with anthrax (PubMed : 11544370).. Protective antigen. Mediates the attachment to host cells by binding host cell receptors ANTXR1 and ANTXR2 (PubMed : 11700562, PubMed : 14507921, PubMed : 15243628, PubMed : 15326297). Following host cell surface attachment, PA is cleaved by FURIN to generate the PA-63 (Protective antigen PA-63) form, which constitutes the mature form of the protein that oligomerizes and forms a pore to translocate the enzymatic toxin components edema factor (EF) and lethal factor (LF) into the host cytosol (PubMed : 11700562, PubMed : 15243628, PubMed : 15326297).. Protective antigen PA-63. Mature form that oligomerizes and forms a pore to translocate the enzymatic toxin components edema factor (EF) and lethal factor (LF) into the host cytosol (PubMed : 15243628, PubMed : 15326297). Following attachment to host cell receptors and cleavage by FURIN, homooligomerizes to form ring-shaped oligomers that are in a pre-pore conformation, and associates with EF and LF (PubMed : 10085027, PubMed : 12117959, PubMed : 15313199). Toxin-leaded complexes are then endocytosed in a clathrin-dependent process, followed by a conformational change of oligomerized PA-63 from the pre-pore to pore state, which is triggered by the low pH in the endosome (PubMed : 10085027, PubMed : 12551953, PubMed : 15326297, PubMed : 20221438). Once active, the pore mediates unfolding of EF and LF, which pass through the pore and translocate into the host cytosol (PubMed : 16051798, PubMed : 21037566, PubMed : 32047164, PubMed : 32521227, PubMed : 32810181).
See full target information pagA

제품이 사용된 논문 (8)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Virus genes 61:342-354 PubMed40159353

2025

Antiviral siRNA delivered using attenuated, anthrax toxin protects cells from the cytopathic effects of Zika virus.

Applications

Unspecified application

Species

Unspecified reactive species

Benedita K L Feron,Timothy Gomez,Natalie C Youens,Nourhan A M Mahmoud,Hadeer K S Abdelrahman,Joachim J Bugert,Simon C W Richardson

Microbiology spectrum 12:e0378623 PubMed38899864

2024

c-di-AMP accumulation impairs toxin expression of by down-regulating potassium importers.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Hu,Junmin Yao,Chengfeng Lei,Xiulian Sun

Analytical chemistry 92:7845-7851 PubMed32437125

2020

Dual-Readout Sandwich Immunoassay for Device-Free and Highly Sensitive Anthrax Biomarker Detection.

Applications

Unspecified application

Species

Unspecified reactive species

Isaac N Larkin,Viswanadham Garimella,Gokay Yamankurt,Alexander W Scott,Hang Xing,Chad A Mirkin

Journal of bacteriology 202: PubMed32071095

2020

Increased Excess Intracellular Cyclic di-AMP Levels Impair Growth and Virulence of Bacillus anthracis.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Hu,Gaobo Zhang,Leiqin Liang,Chengfeng Lei,Xiulian Sun

Journal of controlled release : official journal of the Controlled Release Society 220:316-328 PubMed26546271

2015

Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Paul D R Dyer,Thomas R Shepherd,Alexander S Gollings,Susan A Shorter,Monique A M Gorringe-Pattrick,Chun-Kit Tang,Beatrice N Cattoz,Les Baillie,Peter C Griffiths,Simon C W Richardson

Letters in applied microbiology 54:306-12 PubMed22268495

2012

Comparative analysis of virulence factors secreted by Bacillus anthracis Sterne at host body temperature.

Applications

Unspecified application

Species

Unspecified reactive species

S K Kim,S Shahid,S H Kim,J H Park,H T Lee,K H Jung,Y G Chai

Infection and immunity 79:3012-9 PubMed21576337

2011

Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.

Applications

WB

Species

Unspecified reactive species

Melissa K Wilson,James M Vergis,Farhang Alem,John R Palmer,Andrea M Keane-Myers,Trupti N Brahmbhatt,Christy L Ventura,Alison D O'Brien

Proceedings of the National Academy of Sciences of 107:15583-8 PubMed20713715

2010

Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.

Applications

WB

Species

Unspecified reactive species

Mikhail Martchenko,Sun-Young Jeong,Stanley N Cohen
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com